femoston conti 0.5mg/2.5mg film-coated tablets
mylan ire healthcare limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - dydrogesterone, estradiol - film-coated tablet - dydrogesterone 2.5 mg estradiol 0.5 mg - sex hormones and modulators of the genital system
gelofusine solution for infusion 4 %w/v
b. braun medical limited - gelatine polysuccinate sodium chloride sodium hydroxide - solution for infusion - 4 %w/v
geloplasma 3 grams solution for infusion
fresenius kabi limited - modified liquid gelatine, sodium chloride, magnesium chloride hexahydrate, potassium chloride, sodium lactate solution - solution for infusion - 3 grams - blood substitutes and plasma protein fractions
martindale pharma® acetylcysteine 200mg/ml injection
max health limited - acetylcysteine 20%{relative} - concentrate for infusion - 20% w/v - active: acetylcysteine 20%{relative} excipient: disodium edetate sodium hydroxide - n-acetylcysteine is indicated for the treatment of paracetamol overdose in patients: · who present within 15 hours after an acute overdose with a plasma paracetamol level on or above a line joining points of 150mg/l at 4h and 20mg/l at 15h (see nomogram below) or · who have taken more than 200mg/kg or 10g (whichever is less) of sustained release paracetamol or have one of two serum paracetamol levels taken four hours apart on or above a line joining points of 150mg/l at 4h and 20mg/l at 15h (see nomogram below) or · who have taken an acute overdose of paracetamol with opiates or medicines with anticholinergic effects and have one of two serum paracetamol levels taken four hours apart on or above a line joining points of 150mg/l at 4h and 20mg/l at 15h (see nomogram below) or · where there is any doubt over the time of an acute overdose, irrespective of plasma paracetamol level or · who present more than 15 hours after an overdose with abnormal liver biochemistry (inr >1.3 and/or alt>150) or fulminant hepatic failure or · who have taken a staggered overdose irrespective of plasma paracetamol level. staggered is defined as an overdose of 200mg/kg or 10g (whichever is less) over a single 24 hour period or 150mg/kg of 6g (whichever is less) per 24 hour period for at least 48 hours.
arrow - salbutamol
actavis new zealand limited - salbutamol 0.12%{relative} (as salbutamol sulphate) - solution for inhalation - 2.5 mg/2.5ml - active: salbutamol 0.12%{relative} (as salbutamol sulphate) excipient: sodium chloride sulfuric acid water for injection
arrow - salbutamol
actavis new zealand limited - salbutamol 0.24%{relative} (as salbutamol sulphate) - solution for inhalation - 5 mg/2.5ml - active: salbutamol 0.24%{relative} (as salbutamol sulphate) excipient: sodium chloride sulfuric acid water for injection
atropt
pharmacy retailing (nz) ltd t/a healthcare logistics - atropine sulfate monohydrate 0.5%{relative} - eye drops, solution - 0.5 % - active: atropine sulfate monohydrate 0.5%{relative} excipient: benzalkonium chloride boric acid disodium edetate dihydrate hypromellose water
atropt
pharmacy retailing (nz) ltd t/a healthcare logistics - atropine sulfate monohydrate 1%{relative}; - eye drops, solution - 1 % - active: atropine sulfate monohydrate 1%{relative} excipient: benzalkonium chloride boric acid disodium edetate dihydrate hypromellose water
axiron
eli lilly and company (nz) limited - testosterone 2%{relative} - topical solution - 2% w/v - active: testosterone 2%{relative} excipient: ethanol isopropyl alcohol octisalate povidone - androgen replacement therapy for confirmed testosterone deficiency in males
chlorhexidine acetate 0.05% cetrimide 0.5%
baxter healthcare ltd - cetrimide 0.5%{relative}; chlorhexidine acetate 0.05%{relative} - antiseptic solution - 0.05 % - active: cetrimide 0.5%{relative} chlorhexidine acetate 0.05%{relative} excipient: acetic acid tartrazine water for injection - chlorhexidine cetrimide antiseptic solution is used as a general antiseptic. it is used for the cleaning and disinfecting of wounds as an antiseptic treatment for burns.